About Orbis Medicines
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Copenhagen, Denmark
Team Size
1–10 employees
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
orbismedicines.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $93,000,000 · Series-A
Backed by NEA
- Capital Raise
Raised $28,000,000 · Seed
Backed by Forbion Capital Partners
Investors & Backers
Forbion Capital Partners
Lead
NEA
Lead
Cormorant Asset Management
Eli Lilly
Export and Investment Fund
Novo Holdings
Novo Nordisk
Funding History
Series-A equity
· Jan 6, 2025
Round backers: NEA
$93,000,000 startupintros.com
Seed equity
· Feb 1, 2024
Round backers: Forbion Capital Partners
$28,000,000 startupintros.com
Founders & Leadership
Daniela Brodbeck
VP Discovery Biology and Operations
Work email & phone locked
Unlock →
Mikkel Dybkjær
CFO/COO
Work email & phone locked
Unlock →
Morten Graugaard Døssing
CEO
Work email & phone locked
Unlock →
Sevan Habeshian
Founder
Work email & phone locked
Unlock →
Simon Nielsen
Chief Development Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026